Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.
about
Antigen-specific T cell therapies for cancer.Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cellsImmunotherapy against cancer-related viruses.Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine.Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases.A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy.Trial Watch: Adoptively transferred cells for anticancer immunotherapy.Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.
P2860
Q38544740-2DA1C523-F259-4DFD-B8EB-D85B5DFEEE8CQ38568602-7E3A134B-961E-41C2-96F9-D52E1BD6A636Q38741546-CDDCBA36-67BC-4C54-A391-00A51D1BD4F1Q38778924-2503C567-5B16-49AE-ACBD-AD3328B53D3FQ39044990-89DD02F1-5EF7-49DA-A306-00399D8D0938Q45324037-813DFFCA-5D54-4357-B7B6-AB5B620BCF63Q47549907-5E09461C-0728-465A-8DF4-E3AA0D4B361DQ52780137-FA7711D8-0926-40B0-9512-46026ADC3E5BQ55024423-E6E466C3-C274-42F4-A2E9-B50BBF26CA73Q55094448-E39DB73F-C60B-4CA5-8A11-6F2FB0EDB5DB
P2860
Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@ast
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@en
type
label
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@ast
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@en
prefLabel
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@ast
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@en
P2093
P2860
P356
P1433
P1476
Long-term Outcome of Extranoda ...... LMP1 and LMP2a-specific CTLs.
@en
P2093
Byung-Ock Choi
Gyeongsin Park
Hyeon Woo Yim
Hyun-Il Cho
Hyun-Joo Lee
Hyun-Jung Sohn
Jong Wook Lee
Joo Hyun Oh
Nak Gyun Chung
Nayoun Kim
P2860
P304
P356
10.1038/MT.2015.91
P577
2015-05-28T00:00:00Z